Drug polymorphism (a phenomenon in which compounds exhibit the same chemical composition but have a different lattice structure), polymorphic conversion and dehydration behaviour are all issues of ...

The discovery opens up opportunities to study the therapeutic properties of ibogaine and related compounds. Ibogaine, a ...

Net interest income was 14% higher YoY, at ₹587.7 crore, due to steady loan growth & higher interest margins than Q3 FY24 levels of ₹516 crore.

The Capital Structure page of HCL Technologies Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period.